Next Investors logo grey

Unite Us deal flow not yet factored into Auctus share price


Published 31-JUL-2019 14:19 P.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

It looks to be an opportune time to snap up Auctus Alternative Investments Ltd (ASX:AVC). The company is trading in the vicinity of 25 cents per share after receiving strong institutional support in June when the group raised capital at 35 cents per share.

While one of its investments in Boppl was placed into administration on May 9, 2019, the impact of this development was fully explained and understood when Auctus conducted the capital raising some seven weeks later.

From an operational perspective, Auctus Asset Management had a strong quarter, generating over $500,000 in cash receipts.

In addition to the existing Funds, Auctus AM closed out the US$4.8 million investment into Unite Us, a US based technology platform that enables real-time coordination between healthcare and community services, comprehensively tracking the Social Determinants of Health.

The Unite Us Fund invested alongside Oak HC/FT, a US based premier growth-equity fund specialising in healthcare and financial services technology.

New contracts position Unite Us for growth

Unite Us has performed strongly post investment, securing a multi-year contract with Kaiser Permanente (KP) to scale the model and make it available to the 68 million individuals living in communities served by KP.

In addition, last week Unite Us signed an additional multi-year contract with CVS Health to launch a new social care network.

These are important developments for Unite Us, and it could be argued that this news which has only just come to market has the potential to generate positive share price momentum.

Auctus AM’s Assets Under Management and Advice (AUMA) now stands at $25 million, not including the Energy Storage Fund which we will discuss later.

Next Investors Image

Deals in progress

Management continues to conduct in-depth due diligence on a pipeline of unique opportunities which it expects to offer throughout fiscal 2020.

On the deal front, in mid-June Auctus Asset Management announced that it was establishing RBP Partners LLC (RBP) in partnership with an experienced New York based investment team.

In keeping with this announcement Auctus AM launched the US$25 million Energy Storage Fund on June 17.

This represents approximately $35 million in Australian dollar terms.

The Fund has received strong interest since launch and is expected to close during the September quarter.

Management flagged near-term upcoming newsflow in relation to this investment which could provide positive share price momentum.

Restructuring of Gophr investment

In May, Auctus Investment Holdings restructured its shareholding in Gophr.

The investment now consists of a 29% equity holding, an £800,000 Convertible Note and a loan to the founders / management of approximately £1.15 million.

For the 6 months to June 2019, Gophr produced unaudited sales of approximately £1.67 million, a robust performance given the December half is generally the stronger one.

Auctus Asset Management finished the June quarter with $530,000 in cash, but this did not include part of the proceeds of the capital raising which have since been received.

Consequently, the company is in a position to execute on management’s strategy of pursuing other investment opportunities in fiscal 2020.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.